Eagle Pharmaceuticals, Inc.
EGRXDelisted Nov 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000827871
Eagle Pharmaceuticals, Inc. was delisted on Nov 26, 2024; its insiders filed their last Form 4 on Mar 1, 2024; 65 institutions reported holding it in 13F filings for Q3 2024, worth $31.9M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Eagle Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
EGRX is no longer listed, and 13F filings after Q3 2024 list far fewer holders. See Q3 2024
- Institutional holders
- 9
- −55 vs. Q3 2024
- Shares held
- 79.0K
- −8.42M (−99.1%) vs. Q3 2024
- Total value
- $38.8K
- −$31.7M (−99.9%) vs. Q3 2024
- New holders
- 0
- 2 more added
- Sold out
- 55
- 3 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $8.28K |
| Q1 2026 | 2 | $4.21K |
| Q4 2025 | 2 | $8.64K |
| Q3 2025 | 2 | $33.3K |
| Q2 2025 | 2 | $35.8K |
| Q1 2025 | 2 | $12.1K |
| Q4 2024 | 9 | $38.8K |
| Q3 2024 | 65 | $31.9M |
| Q2 2024 | 75 | $55.5M |
| Q1 2024 | 91 | $54.8M |
| Q4 2023 | 104 | $52.4M |
| Q3 2023 | 108 | $162.9M |
| Q2 2023 | 126 | $209.5M |
| Q1 2023 | 153 | $334.2M |
| Q4 2022 | 152 | $337.9M |
| Q3 2022 | 154 | $303.7M |
| Q2 2022 | 164 | $515.8M |
| Q1 2022 | 160 | $555.1M |
| Q4 2021 | 162 | $573.2M |
| Q3 2021 | 151 | $659.5M |
| Q2 2021 | 146 | $516.0M |
| Q1 2021 | 155 | $508.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Eagle Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 23,594 | $11.8K | 0.00% | +1,157+5.2% | Added |
| Simplex Trading, LLC | 18,162 | $9.00K | 0.00% | +9,807+117.4% | Added |
| Barclays PLC | 14,233 | $7.12K | 0.00% | −810−5.4% | Reduced |
| Stanley-Laman Group, Ltd. | 12,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 7,155 | $3.00K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 3,411 | $1.71K | 0.00% | −150−4.2% | Reduced |
| Archer Investment Corp | 350 | $175 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 35 | $18 | 0.00% | −29−45.3% | Reduced |
| Credit Agricole S A | 36 | $18 | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −2,356,536−100.0% | Sold out |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −1,211,509−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,000,389−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −579,507−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −374,992−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −268,169−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −256,350−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −223,353−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −192,213−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −185,058−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −183,592−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −150,611−100.0% | Sold out |
| RBF Capital, LLC | 0 | $0 | 0.00% | −143,078−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −121,559−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −119,312−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −118,857−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −105,846−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −82,775−100.0% | Sold out |
| DGS Capital Management, LLC | 0 | $0 | 0.00% | −71,728−100.0% | Sold out |
| Union Square Park Capital Management, LLC | 0 | $0 | 0.00% | −56,963−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −54,625−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −51,006−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −48,800−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −43,723−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −36,925−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −35,820−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −31,955−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −31,900−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −31,495−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −30,011−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −28,348−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −26,013−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −25,837−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −17,976−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −15,686−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −15,530−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −13,821−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −12,952−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,890−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −11,396−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,734−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −7,773−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −6,152−100.0% | Sold out |
| WealthCollab, LLC | 0 | $0 | 0.00% | −5,617−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,702−100.0% | Sold out |
| HighMark Wealth Management LLC | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −1,674−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −785−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −480−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| AJOVista, LLC | – | – | – | – | Not filed |